Lack of knowledge: breast cancer and the soluble interleukin-6 receptor.
about
Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies.Interleukin-6 induces malignant transformation of rat mesenchymal stem cells in association with enhanced signaling of signal transducer and activator of transcription 3.Cancer prevention and therapy through the modulation of the tumor microenvironment.IL-6/IL-6R as a potential key signaling pathway in prostate cancer development.Tumor necrosis factor-alpha-converting enzyme activities and tumor-associated macrophages in breast cancer.Soluble interleukin-6 receptor mediated fatigue highlights immunological heterogeneity of patients with early breast cancer who undergo radiation therapy
P2860
Lack of knowledge: breast cancer and the soluble interleukin-6 receptor.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Lack of knowledge: breast cancer and the soluble interleukin-6 receptor.
@ast
Lack of knowledge: breast cancer and the soluble interleukin-6 receptor.
@en
Lack of knowledge: breast cancer and the soluble interleukin-6 receptor.
@nl
type
label
Lack of knowledge: breast cancer and the soluble interleukin-6 receptor.
@ast
Lack of knowledge: breast cancer and the soluble interleukin-6 receptor.
@en
Lack of knowledge: breast cancer and the soluble interleukin-6 receptor.
@nl
prefLabel
Lack of knowledge: breast cancer and the soluble interleukin-6 receptor.
@ast
Lack of knowledge: breast cancer and the soluble interleukin-6 receptor.
@en
Lack of knowledge: breast cancer and the soluble interleukin-6 receptor.
@nl
P2860
P356
P1433
P1476
Lack of knowledge: breast cancer and the soluble interleukin-6 receptor.
@en
P2093
Heike Knüpfer
Rainer Preiss
P2860
P304
P356
10.1159/000314248
P577
2010-06-01T00:00:00Z